News | News By Subject | News by Disease News By Date | Search News

Disease News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Exelixis, Inc. (EXEL) Chops 70 Percent Of Workforce After Prostate Drug Cabozantinib Fails Pivotal Study     9/2/2014
Novartis AG (NVS)'s New Heart Drug Cuts Cardiovascular Death Risk By 20 Percent; "Most Exciting Ever" Med Points To Huge Sales     9/2/2014
Early Phase 3 Data Suggest Sanofi (France) (SAN.PA), Regeneron Pharmaceuticals, Inc. (REGN) Drug May Halve Heart Risk     9/2/2014
Resverlogix Corporation (RVX.TO)'s RVX-208 Leads To A 77 Percent Relative Risk Reduction Of Major Heart Events     9/2/2014
San Diego's ACADIA Pharmaceuticals, Inc. (ACAD) Wins FDA Breakthrough Therapy Designation For NUPLAZID™     9/2/2014
Bristol-Myers Squibb Company (BMY) Gives Back Rights To Alder Biopharmaceuticals Inc.'s Promising Arthritis Drug Clazakizumab     9/2/2014
Cipla Ltd. Takes A Bite Out Of GlaxoSmithKline (GSK)'s Profits As Copy Of Top Asthma Drug Lauches In Germany, Sweden     9/2/2014
Amgen (AMGN) Submits Marketing Authorization Application For Cholesterol-Lowering Medication Evolocumab     9/2/2014
Amgen (AMGN) Submits Marketing Authorization Application For Talimogene Laherparepvec     9/2/2014
XBiotech USA, Inc. Halts Cancer Study On Positive Phase 3 Results     9/2/2014
AstraZeneca PLC (AZN) Pops On Possibility Of Another Pfizer Inc. (PFE) Bid; Start Of New Cancer Trial     8/29/2014
Hundreds Of Girls Struck With Mystery Illness; Possibly Linked To Merck & Co., Inc. (MRK)'s Gardasil     8/29/2014
Eli Lilly and Company (LLY), Takeda Pharmaceutical Co. Ltd. (TKPYY) Lose Bid To Overturn $9 Billion Award For Hiding Actos' Cancer Risk     8/29/2014
Biocryst Pharmaceuticals (BCRX) Expected To Jump Into Ebola Race In A Few Weeks     8/29/2014
Amgen (AMGN)'s Cholesterol Lowering Drug Succeeds In Phase 3 Trial     8/29/2014

Featured Stories
Wine Only Protects The Heart When You Exercise, Palacky University Study     9/2/2014
Drinking Tea, Not Coffee, Could Help You Live Longer, European Society of Cardiology Reveals     9/2/2014
Dieting? Low-Carb Trumps Low-Fat For Weight Loss, Heart Health, Tulane University Study     9/2/2014
Energy Drinks Cause Heart Problems, European Society of Cardiology Reveals     9/2/2014
Coffee And Nap Can Increase Alertness, Loughborough University Study     9/2/2014
Chinese Farmer Whose Head Was Crushed Will Be Fitted With 3D-Printed Skull, Xijing Hospital Reveals     9/2/2014
Less Sleep In Teen Years Tied To More Pounds At 21, Columbia University Study     8/29/2014
Married Couples Who Smoke Pot Are Happier? University at Buffalo Study     8/29/2014
Marijuana Compound Could Stop Or Slow Down Alzheimer’s, University of South Florida Study     8/29/2014
Prenatal Antidepressants May Be Linked To Autism, Massachusetts General Hospital Study     8/29/2014
This Gene Could Be Boosting Your Chance Of Becoming An Alcoholic, The Scripps Research Institute     8/29/2014
Fighting Prostate Cancer With A Tomato-Rich Diet, University of Bristol Study     8/28/2014
New Estrogen-Based Compound May Curb Binge Eating, Baylor College of Medicine Study     8/28/2014
University of California, San Diego (UCSD) Scientist Finds Clearer Obesity, Diabetes Connection     8/28/2014
Normal-Weight Teens Can Have Eating Disorders Too, The Royal Children's Hospital Study     8/28/2014

More News
Allergan Inc. (AGN) Announces OZURDEX® (Dexamethasone 700 Mcg Intravitreal Implant In Applicator) Now Approved In The European Union For The Treatment Of Diabetic Macular Edema     9/2/2014
New Indication For VIMPAT® (Lacosamide): UCB Group (UCBJF.PK)'s Anti-Epileptic Drug Approved By FDA As Monotherapy In The Treatment Of Patients With Partial-Onset Seizures     9/2/2014
Macrocure (MCUR) Completes Enrollment In Pivotal Phase 3 Clinical Trial Of Curexcell In Diabetic Foot Ulcers     9/2/2014
Sophiris Bio Inc. (SPHS) Reports Completion Of Enrollment In The "PLUS-1" Phase 3 Trial Of PRX302 For Benign Prostatic Hyperplasia     9/2/2014
Teva Pharmaceutical Industries Limited (TEVA)’s Reslizumab Delivers Clinically And Statistically Significant Reduction In Asthma Exacerbations In Two Pivotal Phase 3 Studies     9/2/2014
Ampio Pharmaceuticals, Inc. (AMPE) Release: Update On The Phase 3 Multicenter, Double-Blind STEP Study Of Ampion™ For Osteoarthritis Of The Knee     9/2/2014
Conatus Pharmaceuticals Inc. Initiates Phase 2 Trial In Patients With Liver Cirrhosis And Separate Open Label Phase 2 Trial In Cirrhosis Patients With Portal Hypertension     9/2/2014
Alcobra (ADHD) Announces Enrollment Of First Patient In Phase 2b Clinical Trial Of MDX In Adolescents With ADHD     9/2/2014
Cellular Biomedicine Group (CBMG) Launches Clinical Research Study For Cartilage Defect Stem Cell Therapy     9/2/2014
Nuvilex (NVLX) Submits Application For Orphan Drug Designation To The European Medicines Agency For Its Cell-In-A-Box® Treatment For Pancreatic Cancer     9/2/2014
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) (MSHL) Completes Enrollment In Randomized Phase 2 Clinical Trial Of Pracinostat In Front Line Myelodysplastic Syndrome     9/2/2014
VentiRx Pharmaceuticals, Inc. Announces Fast Track Designation Granted For Motolimod (VTX-2337), A Novel Immunotherapy For Women With Ovarian Cancer     9/2/2014
Capstone Therapeutics (CAPS) Announces Phase 1a Results For AEM-28 Showing Safety And Biomarker Efficacy Signals     9/2/2014
Vifor Pharma Release: CONFIRM-HF Study Demonstrates That Injectafer® (Ferinject®) Improves Exercise Capacity In Patients With Chronic Heart Failure     9/2/2014
Zogenix, Inc. (ZGNX) Release: Zohydro® ER Demonstrates Sustained 12-Hour Pain Relief     9/2/2014

//-->